Patents by Inventor Mark Rubin

Mark Rubin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240082177
    Abstract: The present Disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or a derivative thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.
    Type: Application
    Filed: November 10, 2023
    Publication date: March 14, 2024
    Applicants: MESHABERASE, LLC, The United States of America, as Represented by the Secretary, Department of Health & Human Services
    Inventors: Benjamin Rubin, Mark Gilbert, Jinkyu Jung
  • Publication number: 20230397627
    Abstract: The present disclosure relates generally to the use of fat blends and emulsions of fat blends (such as water-in-oil fat blends) to improve certain features of a comestible product. In certain embodiments, certain water-in-oil emulsions disclosed herein can be suitably used to improve the organoleptic properties, the perceived texture, the perceived juiciness, or the mouthfeel of various foods, pet foods, or feed products, such as meat analogue products.
    Type: Application
    Filed: December 20, 2021
    Publication date: December 14, 2023
    Applicant: Firmenich SA
    Inventors: Howard MUNT, Philipp ERNI, Mark RUBIN, Robert WAGNER, Mirela PASCU
  • Publication number: 20220389523
    Abstract: In general, the presently disclosed technology relates to identification of cancer subtypes. More specifically, the technology relates to methods for determining molecular drivers of cancer and/or progression using a multivariate image data and statistical analysis of in-situ molecular markers and morphological characteristics in the same cells of a biological sample suspected of b cancer. This analysis takes place after a single acquisition that obtains the molecular and anatomic morphology data in parallel. The analysis compares specific morphological and molecular markers to known samples exhibiting particular genetic drivers of the cancer. This method provides statistical information that allows for an increased confidence in the identification of specific molecular drivers of the cancer.
    Type: Application
    Filed: August 5, 2022
    Publication date: December 8, 2022
    Inventors: Francesca Demichelis, Karl Garsha, Phillip C. Miller, Ray B. Nagle, Michael Otter, Gary Anthony Pestano, Mark Rubin
  • Publication number: 20220329697
    Abstract: Systems and methods for determining if a service interruption is associated with a placed toll-free call and if so, routing future toll-free calls to an alternative carrier route to ensure that subsequently placed toll-free calls are connected with the toll-free subscriber.
    Type: Application
    Filed: March 15, 2022
    Publication date: October 13, 2022
    Inventors: Nicholas W. Reifschneider, Brett A. Scorza, Mark Rubin
  • Patent number: 11441189
    Abstract: In general, the presently disclosed technology relates to identification of cancer subtypes. More specifically, the technology relates to methods for determining molecular drivers of cancer and/or progression using a multivariate image data and statistical analysis of in-situ molecular markers and morphological characteristics in the same cells of a biological sample suspected of b cancer. This analysis takes place after a single acquisition that obtains the molecular and anatomic morphology data in parallel. The analysis compares specific morphological and molecular markers to known samples exhibiting particular genetic drivers of the cancer. This method provides statistical information that allows for an increased confidence in the identification of specific molecular drivers of the cancer.
    Type: Grant
    Filed: April 12, 2018
    Date of Patent: September 13, 2022
    Assignees: Ventana Medical Systems, Inc., Cornell University
    Inventors: Francesca Demichelis, Karl Garsha, Phillip C. Miller, Ray B. Nagle, Michael Otter, Gary Anthony Pestano, Mark Rubin
  • Publication number: 20220167642
    Abstract: The present disclosure relates generally to fat blends, emulsions of fat blends (such as water-in-oil fat blends), and uses thereof. In certain embodiments, certain water-in-oil emulsions disclosed herein can be suitably used to improve the organoleptic properties, the perceived texture, the perceived juiciness, or the mouthfeel of various foods, pet foods, or feed products, such as meat analogue products. In certain aspects, the disclosure also relates to the use of the water-in-oil emulsion disclosed herein as a partial or full replacement of animal in various foods, pet foods, or feed products. In certain aspects, the disclosure also relates to methods of preparing water-in-oil emulsions and various food products comprising such water-in-oil emulsion.
    Type: Application
    Filed: June 26, 2020
    Publication date: June 2, 2022
    Applicant: Firmenich SA
    Inventors: Philipp ERNI, Mark RUBIN, Howard MUNT, Robert WAGNER, Mirela PASCU
  • Patent number: 11247048
    Abstract: A gait modulation system including: (a) a sensor device including a sensor adapted for associating with at least one lower limb of the patient, the sensor for transducing at least one parameter related to a gait of the patient, so as to obtain gait data related to the gait, and (b) a muscle stimulator including: (i) an electrical stimulation circuit, the circuit adapted to supply an electrical stimulation output to an electrode array for performing functional electrical stimulation of at least one muscle of the lower limb, and (ii) a microprocessor, operatively connected to the at least one sensor, the microprocessor adapted for: receiving a stream of gait information based on the gait data; processing the gait information, and controlling the stimulation output based on the processing of the gait information, and wherein the microprocessor is further adapted to identify a failure in the stream of gait information, and to consequently control the electrical stimulation circuit to deliver a fail-safe stimulati
    Type: Grant
    Filed: January 27, 2020
    Date of Patent: February 15, 2022
    Assignee: Bioness Neuromodulation Ltd.
    Inventors: Eyal Lasko, Shmuel Springer, Mark Rubin, Amit Dar
  • Publication number: 20200234307
    Abstract: The present disclosure relates to systems, methods, and computer readable media for detecting periodic sequences of events. A computer-implemented method may include collecting processing times and values associated with each of a plurality of events. The method may also include assigning each of the plurality of events to at least one of a plurality of time phases, the plurality of time phases forming a period characteristic of the plurality of events. The method may also include grouping the events in each of the plurality of time phases into one or more clusters, based on the respective values associated with the events. The method may also include determining a periodic sequence of events based on the one or more clusters. The method may further include recording the periodic sequence of events in a database of periodic sequences.
    Type: Application
    Filed: March 18, 2020
    Publication date: July 23, 2020
    Applicant: FIS Financial Compliance Solutions, LLC
    Inventors: Mark A. Rubin, Stanley Tam, Minghai Li
  • Patent number: 10685072
    Abstract: An Internet or other online service is personalized or customized based on data collected for a user of a computing device. In one embodiment, a method includes: storing a plurality of person profiles for persons associated with communications received by a user of a computing device; receiving data associated with an online service; and filtering, using at least one processor, the data based on the plurality of person profiles, wherein the filtered data is for display to the user on the computing device.
    Type: Grant
    Filed: February 7, 2017
    Date of Patent: June 16, 2020
    Assignee: OATH INC.
    Inventors: Mark Rubin, Brian Hein
  • Patent number: 10668381
    Abstract: A system and method are provided for transparently styling non-player characters (“NPCs”) in multiplayer video games such that it is difficult to distinguish between human players and computer-controlled NPCs. NPCs may be styled to resemble human players in terms of both player profile attributes and gameplay actions such that players may not recognize NPCs as non-human, computer-controlled players. Additionally, or alternatively, NPCs and/or human players may be presented with a limited set of profile attributes that may reduce or eliminate the ability to distinguish between human players and NPCs, one or more profile attributes may be “anonymized,” and/or the ability to view player profiles of human players and/or NPCs may be disabled altogether. In certain gameplay sessions including real and/or practice gameplay sessions, human players may be prompted to select from among a predetermined set of playable characters having predefined profile attributes.
    Type: Grant
    Filed: September 25, 2018
    Date of Patent: June 2, 2020
    Assignee: Activision Publishing, Inc.
    Inventors: Michael Condrey, Mark Rubin
  • Publication number: 20200155842
    Abstract: A gait modulation system including: (a) a sensor device including a sensor adapted for associating with at least one lower limb of the patient, the sensor for transducing at least one parameter related to a gait of the patient, so as to obtain gait data related to the gait, and (b) a muscle stimulator including: (i) an electrical stimulation circuit, the circuit adapted to supply an electrical stimulation output to an electrode array for performing functional electrical stimulation of at least one muscle of the lower limb, and (ii) a microprocessor, operatively connected to the at least one sensor, the microprocessor adapted for: receiving a stream of gait information based on the gait data; processing the gait information, and controlling the stimulation output based on the processing of the gait information, and wherein the microprocessor is further adapted to identify a failure in the stream of gait information, and to consequently control the electrical stimulation circuit to deliver a fail-safe stimulati
    Type: Application
    Filed: January 27, 2020
    Publication date: May 21, 2020
    Applicant: Bioness Neuromodulation Ltd.
    Inventors: Eyal LASKO, Shmuel SPRINGER, Mark RUBIN, Amit DAR
  • Patent number: 10543365
    Abstract: A gait modulation system including: (a) a sensor device including a sensor adapted for associating with at least one lower limb of the patient, the sensor for transducing at least one parameter related to a gait of the patient, so as to obtain gait data related to the gait, and (b) a muscle stimulator including: (i) an electrical stimulation circuit, the circuit adapted to supply an electrical stimulation output to an electrode array for performing functional electrical stimulation of at least one muscle of the lower limb, and (ii) a microprocessor, operatively connected to the at least one sensor, the microprocessor adapted for: receiving a stream of gait information based on the gait data; processing the gait information, and controlling the stimulation output based on the processing of the gait information, and wherein the microprocessor is further adapted to identify a failure in the stream of gait information, and to consequently control the electrical stimulation circuit to deliver a fail-safe stimulati
    Type: Grant
    Filed: July 9, 2018
    Date of Patent: January 28, 2020
    Assignee: Bioness Neuromodulation Ltd.
    Inventors: Eyal Lasko, Shmuel Springer, Mark Rubin, Amit Dar
  • Patent number: 10445716
    Abstract: Activation of a payment instrument via an interaction with a payment reader is described herein. A request for a payment instrument that is to be associated with an account of the merchant that is maintained in a ledger of a payment processing service can be received from a point-of-sale (POS) application associated with a merchant device of a merchant. The merchant device can receive a request to activate the payment instrument and can prompt the merchant to cause an interaction between the payment instrument and a payment reader associated with the merchant device. Payment data associated with the payment instrument can be received from the payment reader, and it can be determined that the payment data corresponds to known payment data associated with the payment instrument. Accordingly, the payment instrument can be activated to enable the merchant to use the payment instrument for accessing the account.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: October 15, 2019
    Assignee: Square, Inc.
    Inventors: Christina Riechers, Zachary Margolis, Michael Cormier, Bora Fezga, Clay Robbins, Mark Rubin, Swapnil Chavan
  • Patent number: 10443102
    Abstract: The invention relates generally to new prostate cancer markers, and particularly to a class of cancer marked by the presence of missense mutations in SPOP, an E3 ubiquitin ligase component. The invention provides methods and materials for detecting and diagnosing prostate cancer by detecting these mutations and may be useful in predicting disease progression and response to therapy.
    Type: Grant
    Filed: February 9, 2012
    Date of Patent: October 15, 2019
    Assignee: Cornell University
    Inventors: Mark A. Rubin, Christopher Barbieri
  • Publication number: 20190291007
    Abstract: A system and method are provided for transparently styling non-player characters (“NPCs”) in multiplayer video games such that it is difficult to distinguish between human players and computer-controlled NPCs. NPCs may be styled to resemble human players in terms of both player profile attributes and gameplay actions such that players may not recognize NPCs as non-human, computer-controlled players. Additionally, or alternatively, NPCs and/or human players may be presented with a limited set of profile attributes that may reduce or eliminate the ability to distinguish between human players and NPCs, one or more profile attributes may be “anonymized,” and/or the ability to view player profiles of human players and/or NPCs may be disabled altogether. In certain gameplay sessions including real and/or practice gameplay sessions, human players may be prompted to select from among a predetermined set of playable characters having predefined profile attributes.
    Type: Application
    Filed: September 25, 2018
    Publication date: September 26, 2019
    Inventors: Michael Condrey, Mark Rubin
  • Patent number: 10294476
    Abstract: This invention relates to diagnosis and prognosis of prostate cancer, as well as therapeutic treatment of prostate cancer. More specifically, the invention provides diagnostic and prognostic methods based on detecting nuclear enriched abundant transcript 1 (NEAT1) levels in a sample. Further provided are methods for treating prostate cancer based on targeting NEAT1 via interfering RNA.
    Type: Grant
    Filed: April 17, 2015
    Date of Patent: May 21, 2019
    Assignee: CORNELL UNIVERSITY
    Inventors: Dimple Chakravarty, Mark A. Rubin
  • Publication number: 20190114640
    Abstract: The present disclosure relates to systems, methods, and computer readable media for detecting periodic sequences of events. A computer-implemented method may include collecting processing times and values associated with each of a plurality of events. The method may also include assigning each of the plurality of events to at least one of a plurality of time phases, the plurality of time phases forming a period characteristic of the plurality of events. The method may also include grouping the events in each of the plurality of time phases into one or more clusters, based on the respective values associated with the events. The method may also include determining a periodic sequence of events based on the one or more clusters. The method may further include recording the periodic sequence of events in a database of periodic sequences.
    Type: Application
    Filed: October 18, 2018
    Publication date: April 18, 2019
    Applicant: FIS Financial Compliance Solutions, LLC
    Inventors: MARK A. RUBIN, Stanley Tam, Minghai Li
  • Patent number: 10190173
    Abstract: Recurrent gene fusions of androgen regulated genes and ETS family member genes in prostate cancer are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.
    Type: Grant
    Filed: May 9, 2016
    Date of Patent: January 29, 2019
    Assignees: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Scott Tomlins, Daniel Rhodes, Arul Chinnaiyan, Rohit Mehra, Mark A. Rubin, Xiao-Wei Sun, Sven Perner, Charles Lee, Francesca Demichelis
  • Publication number: 20190009086
    Abstract: A gait modulation system including: (a) a sensor device including a sensor adapted for associating with at least one lower limb of the patient, the sensor for transducing at least one parameter related to a gait of the patient, so as to obtain gait data related to the gait, and (b) a muscle stimulator including: (i) an electrical stimulation circuit, the circuit adapted to supply an electrical stimulation output to an electrode array for performing functional electrical stimulation of at least one muscle of the lower limb, and (ii) a microprocessor, operatively connected to the at least one sensor, the microprocessor adapted for: receiving a stream of gait information based on the gait data; processing the gait information, and controlling the stimulation output based on the processing of the gait information, and wherein the microprocessor is further adapted to identify a failure in the stream of gait information, and to consequently control the electrical stimulation circuit to deliver a fail-safe stimulati
    Type: Application
    Filed: July 9, 2018
    Publication date: January 10, 2019
    Applicant: Bioness Neuromodulation Ltd.
    Inventors: Eyal LASKO, Shmuel SPRINGER, Mark RUBIN, Amit DAR
  • Patent number: 10118099
    Abstract: A system and method are provided for transparently styling non-player characters (“NPCs”) in multiplayer video games such that it is difficult to distinguish between human players and computer-controlled NPCs. NPCs may be styled to resemble human players in terms of both player profile attributes and gameplay actions such that players may not recognize NPCs as non-human, computer-controlled players. Additionally, or alternatively, NPCs and/or human players may be presented with a limited set of profile attributes that may reduce or eliminate the ability to distinguish between human players and NPCs, one or more profile attributes may be “anonymized,” and/or the ability to view player profiles of human players and/or NPCs may be disabled altogether. In certain gameplay sessions including real and/or practice gameplay sessions, human players may be prompted to select from among a predetermined set of playable characters having predefined profile attributes.
    Type: Grant
    Filed: December 16, 2014
    Date of Patent: November 6, 2018
    Assignee: ACTIVISION PUBLISHING, INC.
    Inventors: Michael Condrey, Mark Rubin